Bioversys

Developer of therapeutics for Antimicrobial Resistance

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2008 groups24 employees language bioversys.com

Registered entities

Social engagement

Social engagement: 9K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include AMR Action Fund.

Investor typeCountShare
Venture capital217%
Private equity18%
Angel & family office18%
Accelerator & incubator217%
Other / undisclosed650%

Recent activity

16 Jun 2026
Leadership hire
co-signatory
15 Jun 2026
Event
24th EFMC-YSN MedChemBioOnline
8 Jun 2026
Event
Commerzbank and ODDO BHF Swiss Equities Conference
Coming soon